findmyKOL
Clinical trialNCT06822426RecruitingPhase 3Interventional

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

SponsorCorMedixEnrollment200Central Line Associated Blood Stream Infections (CLABSI)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Turkey (Türkiye)
  • Hacettepe University Hospitals

    Altındağ, Ankara, Turkey (Türkiye)

    Not, yet, recruiting
  • Hacettepe University Hospitals

    Yenimahalle, Ankara, Turkey (Türkiye)

    Not, yet, recruiting
  • Ankara Bilkent City Hospital

    Çankaya, Ankara, Turkey (Türkiye)

    Not, yet, recruiting
  • Ankara University Ibni Sina Research and Application Hospital

    Çankaya, Ankara, Turkey (Türkiye)

    Not, yet, recruiting
  • Istanbul University Faculty of Medicine, Capa State Hospital

    Istanbul, Turkey (Türkiye)

    Not, yet, recruiting
United States
  • University of California Los Angeles

    Los Angeles, California, United States

    Recruiting
  • Medstar Health Research Institute

    Washington D.C., District of Columbia, United States

    Recruiting
  • Bioresearch Partner

    Doral, Florida, United States

    Recruiting
  • Emory University Hospital - Gcrc

    Atlanta, Georgia, United States

    Recruiting
  • University of Chicago Medical Center

    Chicago, Illinois, United States

    Recruiting
  • University of Iowa Health Care

    Iowa City, Iowa, United States

    Recruiting
  • Johns Hopkins Clinical Research Unit

    Baltimore, Maryland, United States

    Recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    Recruiting
  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

    Recruiting
  • Columbia University Irving Medical Center

    New York, New York, United States

    Recruiting
  • Mount Sinai Medical Center

    New York, New York, United States

    Recruiting
  • Duke University Hospital

    Durham, North Carolina, United States

    Withdrawn
  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

    Recruiting
  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Recruiting
  • Rhode Island Hospital

    Providence, Rhode Island, United States

    Recruiting
  • Vanderbilt Center for Human Nutrition

    Nashville, Tennessee, United States

    Recruiting
  • Alchemi - Sugarland

    Sugar Land, Texas, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 May 2025
Primary completion
31 Jan 2028
Completion
31 Jan 2028
Last update posted
20 May 2026
Registered enrollment
200
Registry id
NCT06822426

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.